Form 4: Celcuity Inc. Director Richard E. Buller Reports Acquisition of Shares and Stock Options

Director Richard E. Buller reports acquiring shares of common stock and stock options in Celcuity Inc.

Summary

• On June 4, 2024, Richard E. Buller, a director of Celcuity Inc., reported acquiring 1,079 shares of common stock at $0 and 6,522 stock options with an exercise price of $14.83.
• Following the transaction, Buller directly owns 6,852 shares of common stock and indirectly owns 1,958 shares through a trust.
• Buller also indirectly owns various stock options through a trust with exercise prices ranging from $5.1 to $5.5, and one block of options directly owned with an exercise price of $9.58.
• The newly acquired options vest on April 30, 2025, or the date of the company's 2025 Annual Meeting of Stockholders.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of shares by a director is generally viewed as a positive sign, but it's not a major event.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, common in the biopharmaceutical industry where stock options are frequently used as part of executive compensation packages.

Comparison to Industry Standards

• Stock option grants are a common component of compensation packages for directors and executives in the biotechnology industry, similar to companies like Amgen, Gilead Sciences, and Biogen.
• The vesting schedule of the options, tied to the annual meeting, is a standard practice to align executive incentives with shareholder value creation.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.

Key Dates